135 related articles for article (PubMed ID: 15717247)
21. Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.
McLaughlin JM; Johnson MH; Kagan SA; Baer SL
Infection; 2015 Dec; 43(6):671-80. PubMed ID: 25980561
[TBL] [Abstract][Full Text] [Related]
22. Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort.
Eurich DT; Marrie TJ; Minhas-Sandhu JK; Majumdar SR
Am J Respir Crit Care Med; 2015 Sep; 192(5):597-604. PubMed ID: 26067221
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for developing acute kidney injury in older people with diabetes and community-acquired pneumonia: a population-based UK cohort study.
Jain A; McDonald HI; Nitsch D; Tomlinson L; Thomas SL
BMC Nephrol; 2017 May; 18(1):142. PubMed ID: 28460637
[TBL] [Abstract][Full Text] [Related]
24. Community-acquired pneumonia in children.
Cardinale F; Cappiello AR; Mastrototaro MF; Pignatelli M; Esposito S
Early Hum Dev; 2013 Oct; 89 Suppl 3():S49-52. PubMed ID: 23962481
[TBL] [Abstract][Full Text] [Related]
25. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
[TBL] [Abstract][Full Text] [Related]
26. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
27. Low levels of serum cholesterol and albumin and the risk of community-acquired pneumonia in young soldiers.
Kang DR; Kim YK; Park MS; Kim YS; Ko DH; Kim C
Int J Tuberc Lung Dis; 2008 Jan; 12(1):26-32. PubMed ID: 18173873
[TBL] [Abstract][Full Text] [Related]
28. Population-based burden of pneumonia before school entry in Schleswig-Holstein, Germany.
Weigl JA; Bader HM; Everding A; Schmitt HJ
Eur J Pediatr; 2003 May; 162(5):309-16. PubMed ID: 12692711
[TBL] [Abstract][Full Text] [Related]
29. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.
Fine MJ; Smith MA; Carson CA; Mutha SS; Sankey SS; Weissfeld LA; Kapoor WN
JAMA; 1996 Jan; 275(2):134-41. PubMed ID: 8531309
[TBL] [Abstract][Full Text] [Related]
30. Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients.
Polverino E; Cilloniz C; Menendez R; Gabarrus A; Rosales-Mayor E; Alcaraz V; Terraneo S; Puig de la Bella Casa J; Mensa J; Ferrer M; Torres A
J Infect; 2015 Jul; 71(1):28-36. PubMed ID: 25882347
[TBL] [Abstract][Full Text] [Related]
31. What is the seasonal distribution of community acquired pneumonia over time? A systematic review.
Murdoch KM; Mitra B; Lambert S; Erbas B
Australas Emerg Nurs J; 2014 Feb; 17(1):30-42. PubMed ID: 24507181
[TBL] [Abstract][Full Text] [Related]
32. The burden of hospitalised pneumonia in Lazio, Italy, 1997-1999.
Giorgi Rossi P; Agabiti N; Faustini A; Ancona C; Tancioni V; Forastiere F; Perucci CA
Int J Tuberc Lung Dis; 2004 May; 8(5):528-36. PubMed ID: 15137527
[TBL] [Abstract][Full Text] [Related]
33. Measuring the incidence of adult community-acquired pneumonia in a Native American community.
Watt JP; Moïsi JC; Donaldson RL; Reid R; Ferro S; Whitney CG; Santosham M; O'Brien KL
Epidemiol Infect; 2010 Aug; 138(8):1146-54. PubMed ID: 20056013
[TBL] [Abstract][Full Text] [Related]
34. Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009.
Froes F; Diniz A; Mesquita M; Serrado M; Nunes B
Eur Respir J; 2013 May; 41(5):1141-6. PubMed ID: 22878871
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of community acquired pneumonia.
Deshpande A
J Assoc Physicians India; 2012 Jan; 60 Suppl():6. PubMed ID: 23155816
[No Abstract] [Full Text] [Related]
36. Proportion of community-acquired pneumonia cases attributable to tobacco smoking.
Almirall J; González CA; Balanzó X; Bolíbar I
Chest; 1999 Aug; 116(2):375-9. PubMed ID: 10453865
[TBL] [Abstract][Full Text] [Related]
37. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
38. [Strategies for the Treatment of Community-Acquired Pneumonia in HIV-Positive Patients].
Schleenvoigt BT; Rupp J; Rohde G; Rockstroh JK; Fätkenheuer G; Pletz MW
Pneumologie; 2017 Apr; 71(4):207-214. PubMed ID: 28407674
[No Abstract] [Full Text] [Related]
39. Community-acquired pneumonia with risk for drug-resistant pathogens.
Fleming V; Buck B; Nix N; Kumar P; Southwood R
South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia.
Corrales-Medina VF; Taljaard M; Fine MJ; Dwivedi G; Perry JJ; Musher DM; Chirinos JA
Mayo Clin Proc; 2014 Jan; 89(1):60-8. PubMed ID: 24388023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
